{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:12:26Z","timestamp":1778645546734,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484169&20230484295"],"award-info":[{"award-number":["20220484169&20230484295"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Capital\u2019s Funds for Health Improvement and Research","award":["2024-1-1041"],"award-info":[{"award-number":["2024-1-1041"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z221100007422064"],"award-info":[{"award-number":["Z221100007422064"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Tongzhou District Science and Technology Commission key project","award":["KJ2024CX028"],"award-info":[{"award-number":["KJ2024CX028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s15010-025-02571-3","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T13:33:59Z","timestamp":1748180039000},"page":"2397-2410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection"],"prefix":"10.1007","volume":"53","author":[{"given":"Chunyan","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weicong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujie","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"12","key":"2571_CR1","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1164\/rccm.202007-2686OC","volume":"203","author":"CAM Mpande","year":"2021","unstructured":"Mpande CAM, Musvosvi M, Rozot V, et al. Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection. Am J Respir Crit Care Med. 2021;203(12):1556\u201365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2571_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.15585\/mmwr.mm6811a3","volume":"68","author":"A MacNeil","year":"2019","unstructured":"MacNeil A, Glaziou P, Sismanidis C, et al. Global epidemiology of tuberculosis and progress toward achieving global targets-2017. Morb Mortal Wkly Rep. 2019;68(11):263\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"key":"2571_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103233","author":"CAM Mpande","year":"2021","unstructured":"Mpande CAM, Rozot V, Mosito B, et al. Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection. EBioMedicine. 2021. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103233.","journal-title":"EBioMedicine"},{"issue":"9","key":"2571_CR4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/infdis\/jix107","volume":"215","author":"A Halliday","year":"2017","unstructured":"Halliday A, Whitworth H, Kottoor SH, et al. Stratification of latent Mycobacterium tuberculosis infection by cellular immune profiling. J Infect Dis. 2017;215(9):1480\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"2571_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1183\/13993003.01157-2016","volume":"48","author":"CGM Erkens","year":"2016","unstructured":"Erkens CGM, Slump E, Verhagen M, et al. Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands. Eur Respir J. 2016;48(5):1420\u20138.","journal-title":"Eur Respir J"},{"key":"2571_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5770","author":"MA Behr","year":"2019","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019. https:\/\/doi.org\/10.1136\/bmj.l5770.","journal-title":"BMJ"},{"key":"2571_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73942-z","author":"RC Ault","year":"2020","unstructured":"Ault RC, Headley CA, Hare AE, et al. Blood RNA signatures predict recent tuberculosis exposure in mice, macaques and humans. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-73942-z.","journal-title":"Sci Rep"},{"issue":"1","key":"2571_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/ers.10.81","volume":"5","author":"S McCormick","year":"2011","unstructured":"McCormick S, Shaler CR, Xing Z. Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy. Expert Rev Respir Med. 2011;5(1):75\u201385.","journal-title":"Expert Rev Respir Med"},{"issue":"9","key":"2571_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cmi.2023.10.023","volume":"30","author":"A Vasiliu","year":"2024","unstructured":"Vasiliu A, Martinez L, Gupta RK, et al. Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2024;30(9):1123\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2571_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5588\/ijtld.21.0753","volume":"26","author":"GB Migliori","year":"2022","unstructured":"Migliori GB, Wu SJ, Matteelli A, et al. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int J Tuberc Lung Dis. 2022;26(3):190\u2013205.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"2571_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","volume":"8","author":"E Harding","year":"2020","unstructured":"Harding E. WHO global progress report on tuberculosis elimination (vol 8, pg 19, 2020). Lancet Respir Med. 2020;8(1):19.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"2571_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccm.2019.07.007","volume":"40","author":"MK Haas","year":"2019","unstructured":"Haas MK, Belknap RW. Diagnostic tests for latent tuberculosis infection. Clin Chest Med. 2019;40(4):829\u201337.","journal-title":"Clin Chest Med"},{"issue":"1","key":"2571_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","volume":"27","author":"M Pai","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3\u201320.","journal-title":"Clin Microbiol Rev"},{"key":"2571_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/IDR.S504632","volume":"18","author":"H Zhang","year":"2025","unstructured":"Zhang H, Guan W, Zhou J. Advances in the diagnosis of latent tuberculosis infection. Infect Drug Resist. 2025;18:483\u201393.","journal-title":"Infect Drug Resist"},{"issue":"25","key":"2571_CR15","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1016\/j.cell.2022.10.025","volume":"185","author":"JL Flynn","year":"2022","unstructured":"Flynn JL, Chan J. Immune cell interactions in tuberculosis. Cell. 2022;185(25):4682\u2013702.","journal-title":"Cell"},{"key":"2571_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2024.102567","author":"D Vats","year":"2024","unstructured":"Vats D, Rani G, Arora A, et al. Tuberculosis and T cells: impact of T cell diversity in tuberculosis infection. Tuberculosis. 2024. https:\/\/doi.org\/10.1016\/j.tube.2024.102567.","journal-title":"Tuberculosis"},{"issue":"1","key":"2571_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12274","volume":"264","author":"LD Jasenosky","year":"2015","unstructured":"Jasenosky LD, Scriba TJ, Hanekom WA, et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015;264(1):74\u201387.","journal-title":"Immunol Rev"},{"issue":"3","key":"2571_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jinf.2016.04.036","volume":"73","author":"DO Awoniyi","year":"2016","unstructured":"Awoniyi DO, Teuchert A, Sutherland JS, et al. Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease. J Infect. 2016;73(3):219\u201330.","journal-title":"J Infect"},{"key":"2571_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clim.2017.09.019","volume":"183","author":"D Duffy","year":"2017","unstructured":"Duffy D, Rouilly V, Braudeau C, et al. Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study. Clin Immunol. 2017;183:325\u201335.","journal-title":"Clin Immunol"},{"key":"2571_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","volume":"39","author":"MM Ravesloot-Ch\u00e1vez","year":"2021","unstructured":"Ravesloot-Ch\u00e1vez MM, Van Dis E, Stanley SA. The innate immune response to Mycobacterium tuberculosis infection. Annu Rev Immunol. 2021;39:611\u2013637.  https:\/\/doi.org\/10.1146\/annurev-immunol-093019-010426","journal-title":"Annu Rev Immunol"},{"key":"2571_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","author":"R Domingo-Gonzalez","year":"2016","unstructured":"Domingo-Gonzalez R, Prince O, Cooper A, et al. Cytokines and chemokines in Mycobacterium tuberculosis infection. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0018-2016.","journal-title":"Microbiol Spectr"},{"key":"2571_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1359555","author":"W Ren","year":"2024","unstructured":"Ren W, Ma Z, Li Q, et al. Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1359555.","journal-title":"Front Immunol"},{"issue":"2","key":"2571_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1473-3099(15)00499-5","volume":"16","author":"TA Yates","year":"2016","unstructured":"Yates TA, Khan PY, Knight GM, et al. The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis. 2016;16(2):227\u201338.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2571_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103955","volume":"29","author":"V Singh","year":"2024","unstructured":"Singh V. Tuberculosis treatment-shortening. Drug Discov Today. 2024;29(5): 103955.","journal-title":"Drug Discov Today"},{"issue":"3","key":"2571_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s15010-019-01285-7","volume":"47","author":"MJ Nasiri","year":"2019","unstructured":"Nasiri MJ, Pormohammad A, Goudarzi H, et al. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA. Infection. 2019;47(3):353\u201361.","journal-title":"Infection"},{"key":"2571_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae642","author":"BMF Nogueira","year":"2025","unstructured":"Nogueira BMF, Rangel F, Andrade AMS, et al. Predictive markers of incident tuberculosis in close contacts in Brazil and India. J Infect Dis. 2025. https:\/\/doi.org\/10.1093\/infdis\/jiae642.","journal-title":"J Infect Dis"},{"key":"2571_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129398","author":"M Herrera","year":"2023","unstructured":"Herrera M, Keynan Y, Lopez L, et al. Cytokine\/chemokine profiles in people with recent infection by Mycobacterium tuberculosis. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1129398.","journal-title":"Front Immunol"},{"issue":"3","key":"2571_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/jnci\/djh024","volume":"96","author":"YY Zhang","year":"2004","unstructured":"Zhang YY, Yoneyama H, Wang Y, et al. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1\u03b1 in mice. J Natl Cancer Inst. 2004;96(3):201\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2571_CR29","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1189\/jlb.0708420","volume":"84","author":"S He","year":"2008","unstructured":"He S, Cao Q, Yoneyama H, et al. MIP-3\u03b1 and MIP-1\u03b1 rapidly mobilize dendritic cell precursors into the peripheral blood. J Leukoc Biol. 2008;84(6):1549\u201356.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"2571_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/1744666X.2017.1384313","volume":"13","author":"TH Schaller","year":"2017","unstructured":"Schaller TH, Batich KA, Suryadevara CM, et al. Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. Expert Rev Clin Immunol. 2017;13(11):1049\u201360.","journal-title":"Expert Rev Clin Immunol"},{"key":"2571_CR31","doi-asserted-by":"publisher","DOI":"10.4110\/in.2021.21.e23","author":"TG Kang","year":"2021","unstructured":"Kang TG, Park HJ, Moon J, et al. Enriching CCL3 in the tumor microenvironment facilitates T cell responses and improves the efficacy of anti-PD-1 therapy. Immune Netw. 2021. https:\/\/doi.org\/10.4110\/in.2021.21.e23.","journal-title":"Immune Netw"},{"issue":"5","key":"2571_CR32","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.4049\/jimmunol.1301373","volume":"192","author":"S Yao","year":"2014","unstructured":"Yao S, Huang D, Chen CY, et al. CD4+ t cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ t and CD32- lymphocytes: mechanisms of CD4+ t cell immunity. J Immunol. 2014;192(5):2120\u201332.","journal-title":"J Immunol"},{"key":"2571_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113714","author":"S-Z Dai","year":"2025","unstructured":"Dai S-Z, Wu R-H, Chen H, et al. Progesterone suppresses rhinovirus-induced airway inflammation by inhibiting neutrophil infiltration and extracellular traps formation. Int Immunopharmacol. 2025. https:\/\/doi.org\/10.1016\/j.intimp.2024.113714.","journal-title":"Int Immunopharmacol"},{"key":"2571_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109981","author":"Y Wu","year":"2024","unstructured":"Wu Y, Che J, Dong J, et al. CCR5 antagonist maraviroc alleviates doxorubicin-induced neuroinflammation and neurobehavioral deficiency by regulating NF-KB\/ NLRP3 signaling in a breast cancer mouse model. Neuropharmacology. 2024. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109981.","journal-title":"Neuropharmacology"},{"key":"2571_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18445","author":"C Zhang","year":"2024","unstructured":"Zhang C, Xu S, Hu R-J, et al. Unraveling CCL20\u2019s role by regulating Th17 cell chemotaxis in experimental autoimmune prostatitis. J Cell Mol Med. 2024. https:\/\/doi.org\/10.1111\/jcmm.18445.","journal-title":"J Cell Mol Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:52:51Z","timestamp":1764751971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2571"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02571-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Chest Hospital, Capital Medical University. Board and Ethical Board (approval number: YJS-2022-03). The study adhered to the guidelines set forth in the Declaration of Helsinki and was conducted in compliance with local legislation and institutional requirements. All participants provided written informed consent prior to their involvement in the study. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}